Position in OGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$29,817,766
+$10,094,593 QoQ
Shares Held
2,202,199
-33.1% QoQ
Ownership
0.839%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 625 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $63,698,443,803 across 20 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,226,398 | $19,462,430,163 | |
| 2 | JNJ |
Johnson & Johnson
|
44,808,254 | $11,379,952,259 | |
| 3 | ABBV |
AbbVie Inc.
|
38,901,001 | $9,789,047,884 | |
| 4 | MRK |
Merck & Co., Inc.
|
48,641,158 | $6,250,388,797 | |
| 5 | AMGN |
Amgen Inc
|
13,653,692 | $4,944,274,940 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,004,354 | $3,032,710,073 | |
| 7 | PFE |
Pfizer Inc
|
96,345,452 | $2,319,998,477 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,009,025 | $1,671,500,010 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,817,766 | 2,202,199 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $19,723,173 | 3,292,684 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,794,442 | 3,179,142 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $46,542,536 | 4,357,916 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $55,623,461 | 5,746,226 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $83,571,222 | 5,612,574 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $67,888,487 | 4,550,167 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $97,911,044 | 5,118,194 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $109,746,821 | 5,301,779 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $94,729,812 | 5,038,820 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $84,487,177 | 5,859,028 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $52,695,179 | 3,035,437 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $56,602,631 | 2,719,973 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $62,733,692 | 2,667,249 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $84,149,145 | 3,012,859 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $70,815,391 | 3,026,299 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $101,377,672 | 3,003,783 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $69,576,399 | 1,991,881 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $56,444,491 | 1,853,678 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $65,555,402 | 1,999,250 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $62,477,150 | 2,064,678 | Shares | Defined | 2021-08-23 | |
| No filing history on record for this holder in this stock. | ||||||